A Phase II, Open-label, Single Arm, Multicentre, International Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2017
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms SIMPLIFY
- 15 May 2016 Status changed from not yet recruiting to recruiting.
- 01 Sep 2015 Planned End Date changed to 1 Dec 2018, according to ClinicalTrials.gov record.
- 01 Sep 2015 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2016, according to ClinicalTrials.gov record.